Pemirolast: Difference between revisions
No edit summary |
No edit summary |
||
| Line 50: | Line 50: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Pemirolast''' ([[International Nonproprietary Name|INN]]) is a [[mast cell stabilizer]] used as an anti-allergic drug therapy. It is marketed under the tradenames '''Alegysal''' and '''Alamast'''. | '''Pemirolast''' ([[International Nonproprietary Name|INN]]) is a [[mast cell stabilizer]] used as an anti-allergic drug therapy. It is marketed under the tradenames '''Alegysal''' and '''Alamast'''. | ||
| Line 61: | Line 58: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:H1 receptor antagonists]] | [[Category:H1 receptor antagonists]] | ||
[[Category:Tetrazoles]] | [[Category:Tetrazoles]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Revision as of 12:50, 27 April 2015
 | |
| Clinical data | |
|---|---|
| Trade names | Alamast |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | Oral, ophthalmic |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H8N6O |
| Molar mass | 228.21 g/mol |
| 3D model (JSmol) | |
| |
  (what is this?) (verify) | |
|
WikiDoc Resources for Pemirolast |
|
Articles |
|---|
|
Most recent articles on Pemirolast |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Pemirolast at Clinical Trials.gov Clinical Trials on Pemirolast at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Pemirolast
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Pemirolast Discussion groups on Pemirolast Patient Handouts on Pemirolast Directions to Hospitals Treating Pemirolast Risk calculators and risk factors for Pemirolast
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Pemirolast |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast.
It has also been studied for the treatment of asthma.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without InChI source
- Drugboxes which contain changes to verified fields
- H1 receptor antagonists
- Tetrazoles
- Lactams
- Drug